Xylazine recalls

The FDA has published 1 recall involving Xylazine since 2013. The latest was reported on 17 Jul 2013. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2013

Last 12 months0reported

Class I00% of total

Ongoing1latest 17 Jul 2013

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why xylazine is recalled

Sterility1100%

Companies

Lowlite Investments1100%

By year

20131100%

Ongoing xylazine recalls

1 active

Reported	Class	Recall	Company	Reason	Where
17 Jul 2013Drug	CLASS II	Xylazine 300 mg/ml Injection recalled by Lowlite Investments	Lowlite Investments	Sterility	Nationwide

All xylazine recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
17 Jul 2013Drug	CLASS II	Xylazine 300 mg/ml Injection recalled by Lowlite Investments	Lowlite Investments	Sterility	Nationwide

Should you stop taking Xylazine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.